Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Etonogestrel and Ethinyl Estradiol

CompanyTeva Pharmaceuticals USA, Inc. (DUNS: 001627975)

Effective Date

September 30, 2022

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Etonogestrel(0.120 mg in 1 d)

Ethinylestradiol(0.015 mg in 1 d)

Products (1)

Etonogestrel and Ethinyl Estradiol

NDC Product Code

0093-7679

Application Number

ANDA204305

Marketing Category

ANDA (C73584)

Route of Administration

VAGINAL

Effective Date

September 30, 2022

Ingredients

EtonogestrelActive

Code: 304GTH6RNHClass: ACTIBQuantity: 0.120 mg in 1 d

EthinylestradiolActive

Code: 423D2T571UClass: ACTIBQuantity: 0.015 mg in 1 d

ETHYLENE-VINYL ACETATE COPOLYMER (28% VINYL ACETATE)Inactive

Code: 8ILA5X28VSClass: IACT

ETHYLENE-VINYL ACETATE COPOLYMER (9% VINYLACETATE)Inactive

Code: 4OKC630HS6Class: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy